Agree, natives are restless, drums are beating, pot is boiling ... 

So, it appears we are back to the notion that we have a "yet to be proven academically via FDA trial" combination therapy drug that is safe and has a BTD and appears to work very well for MACE in patients with TB2 + CKD ... a better "defined" and digestible significant commercial market with unmet need and LOTS of stellar preliminary data and a full library of molecules for further development, plus lots iof patent life ... sell it Don. 

Don't make me come over there and sell it for you ... I'll take $500m cash plus funding of the next study now, and and additional $4-5b upon successful completion of BoM2 plus a successful NDA in 1-3 years ...